Integral Health Asset Management
Integral Health Asset Management reported 89 stocks worth $2.4B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RVMD (11.5%), INSM (7.0%) and CYTK (5.6%). Compared with Q1 2026, the fund opened new positions in ABT, UNH and THC, added to INSM, CVS and EWTX, trimmed RYTM, ALHC and MRK and sold out of AZN, ASND and FMS.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  RVMD Revolution Medicines Inc | $281M | 11.5% | 1.5M | No change | 8 of 8 | |
| 2 |  INSM Insmed Inc | $171M | 7.0% | 1.6M | +100K (+7%) | 8 of 8 | |
| 3 |  CYTK Cytokinetics Inc | $136M | 5.6% | 1.6M | No change | 8 of 8 | |
| 4 |  CVS Cvs Health Corp | $114M | 4.7% | 1.1M | +950K (+633%) | 7 of 8 | |
| 5 |  EWTX Edgewise Therapeutics Inc | $81.3M | 3.3% | 2M | +400K (+25%) | 7 of 8 | |
| 6 |  VERA Vera Therapeutics Inc | $75.1M | 3.1% | 1.8M | +150K (+9%) | 8 of 8 | |
| 7 |  AXSM Axsome Therapeutics Inc | $73.4M | 3.0% | 300K | +265K (+757%) | 2 of 8 | |
| 8 |  CAH Cardinal Health Inc | $71.3M | 2.9% | 300K | +30K (+11%) | 6 of 8 | |
| 9 |  ROIV Roivant Sciences Ltd | $70.8M | 2.9% | 2M | No change | 6 of 8 | |
| 10 |  RYTM Rhythm Pharmaceuticals Inc | $61.1M | 2.5% | 550K | −50K (−8%) | 6 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 AZN Astrazeneca PLC Ord | $49.3M | 250K |
 ASND Ascendis Pharma A/s | $26.3M | 115K |
 FMS Fresenius Medical Care AG | $17.5M | 775K |
 ISRG Intuitive Surgical Inc | $16.1M | 35K |
 TARS Tarsus Pharmaceuticals Inc | $14M | 200K |
🔒 Free account: see all 26.
Options
valued at the underlying shares
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Integral Health Asset Management 13F FAQ
What does Integral Health Asset Management own?
Integral Health Asset Management reported 89 stocks worth $2.4B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RVMD (11.5%), INSM (7.0%) and CYTK (5.6%). The table above lists every position in the filing (the top 10 without an account).
What did Integral Health Asset Management buy and sell in Q2 2026?
Compared with Q1 2026: 29 new positions, 23 added to, 20 trimmed and 26 sold out. New positions include ABT, UNH and THC. It sold all of AZN, ASND and FMS.
When will Integral Health Asset Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Integral Health Asset Management's portfolio worth?
The Q2 2026 filing reports $2.4B in US stocks ($2.5B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.